In this video link, JAMA (Journal of American Medical Association) has proven that stem cell transplants in the pancreas has lead to decreased exogenous insulin injections. "Exogenous" means external, or manual; essentially, when one uses stem cells to replace the dying beta cells, he doesn't need to inject himself with insulin as frequently. This allows diabetes patients to live much more normally. In addition, these stem cells may be used in later years to create entire organs for transplanting.
Another source that has further proven this leap in stem cell research is the XCell-Center of Regenerative Medicine. This company has taken a sample of 50 diabetic patients, twenty of whom are diagnosed with IDDM, treated them with their own stem cells, and has given positive results on their current progress. Out of the total 50 patients, 26 (52%) showed an improvement.
Concerning Type 1 Diabetes, 7 observed an improvement, 12 had little or no change, and only one had a slight deterioration. There were multiple signs of improvement from this test. For example, approximately 71% of patients experienced stable blood-glucose levels. In addition, 57% experienced better fasting glucose level, a decrease in glucose level fluctuation, and less frequent dehydration after treatment. These and multiple more results show how stem cell implantation is rapidly turning into a key cure for Diabetes Mellitus Type 1.
No comments:
Post a Comment